Core Viewpoint - Perfectech International (00765) reported a decrease in revenue for the six months ending June 30, 2025, with a total of HKD 61.958 million, representing a year-on-year decline of 9.7% [1] Financial Performance - The company recorded a loss attributable to shareholders of HKD 4.284 million, which is a significant improvement, narrowing by 75.94% year-on-year [1] - Earnings per share were reported at a loss of HKD 0.0131 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 PERFECTECH INTERNATIONAL HOLDINGS LIMITED （於百慕達註冊成立之有限公司） 威發國際集團有限公司* （股份編號：00765） 截至二零二五年六月三十日止六個月之中期業績公告 中期業績 威發國際集團有限公司（「本公司」）董事（「董事」，各自稱為「董事」）會（「董事會」）欣然宣 佈本公司及其附屬公司（「本集團」）於截至二零二五年六月三十日止六個月之未經審核簡 明綜合業績，以及二零二四年同期之比較數字。 簡明綜合損益及其他全面收益表 截至二零二五年六月三十日止六個月 | | | （未經審核） | | | --- | --- | --- | --- | | | | 截至六月三十日止六個月 | | | | | 二零二五年 | 二零二四年 | | | 附註 | 港幣千元 | 港幣千元 | | 收益 | 3及4 | 61,958 | 68,611 | | 銷售成本 | | (4 ...

Core Insights - The article highlights the significant stock adjustments made by the China Europe Medical Health Fund, managed by Ge Lan, during the second quarter of 2025, particularly its increased holdings in several pharmaceutical companies [1][3][4]. Group 1: Fund Adjustments - The China Europe Medical Health Fund entered the top ten circulating shareholders of Lizhu Group and Betta Pharmaceuticals, holding 5.939 million shares and 4.3513 million shares, respectively [3]. - The fund significantly increased its stake in XinNuoWei by approximately 14 million shares, representing a 222% increase, bringing its total holdings to 20.184 million shares [3][4][6]. - Other notable increases included holdings in XinLiTai (up 86% to 26.163 million shares), NuoCheng JianHua (up 43.9% to 13.048 million shares), and HuaDong Pharmaceutical (up 17.39% to 24.4395 million shares) [4][6]. Group 2: Fund Management Strategy - In July, the China Europe Medical Health Fund announced the appointment of Zhao Lei as a co-manager, indicating a shift towards a team-based management approach [8]. - The fund is part of a broader trend within China Europe Fund to enhance its research and investment management capabilities through a "professional, industrialized, and intelligent" investment research system [8][9]. - This transformation aims to create a sustainable organization capable of generating alpha over the long term, thereby improving product offerings and services for investors [9].

Group 1 - The company, PERFECTECH INTL (00765.HK), will hold a board meeting on August 29, 2025, to review and approve its interim results for the six months ending June 30, 2025 [1] - The meeting will also consider the proposal for the distribution of an interim dividend, if any [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 PERFECTECH INTERNATIONAL HOLDINGS LIMITED 威發國際集團有限公司* 承董事會命 威發國際集團有限公司* 執行董事 李邵華 香港，二零二五年八月十五日 於本公告日期，董事會成員包括執行董事李邵華先生、潘偉業先生及钟世辉先生， 以及獨立非執行董事劉樹人先生及陳寶琳女士。 * 僅供識別 （於百慕達註冊成立之有限公司） （股份編號：00765） （「本公司」） 董事會會議通告 威發國際集團有限公司（「本公司」）之董事會（「董事會」）謹此宣佈，將於二零二五年 八月二十九日（星期五）舉行董事會會議，會上將通過本公司及其附屬公司截至二零 二五年六月三十日止六個月之中期業績，並於香港聯合交易所有限公司及本公司之 網站上刊登上述業績。董事會屆時亦會考慮派付截至二零二五年六月三十日止六個 月之中期股息（如有）。 ...

Core Viewpoint - PERFECTECH INTL (00765) expects a significant reduction in comprehensive net loss for the first half of 2025 compared to the same period in 2024, with a decrease of 74% to 79% from a loss of 19.4 million HKD [1] Financial Performance - The anticipated reduction in loss is primarily attributed to an increase in gross margin from 21.4% to 32.6%, driven by lower costs of raw materials and direct labor [1] - Administrative expenses are expected to decrease significantly from 34.3 million HKD to 24.2 million HKD due to reduced employee costs [1]

Group 1 - The company, PERFECTECH INTL (00765), expects a significant reduction in its consolidated net loss for the first half of 2025, projecting a decrease of 74% to 79% compared to a consolidated net loss of 19.4 million HKD in the same period of 2024 [1] - The improvement in loss is attributed to an increase in gross profit margin from 21.4% to 32.6%, primarily due to a reduction in raw material and direct labor costs [1] - Administrative expenses are expected to decrease significantly from 34.3 million HKD to 24.2 million HKD, driven by a reduction in employee costs [1]

Core Viewpoint - PERFECTECH INTL (00765.HK) expects a significant reduction in consolidated net loss for the six months ending June 30, 2025, compared to the previous year's net loss of HKD 19,400,000, with a decrease of 74% to 79% anticipated [1] Financial Performance - The gross profit margin is projected to increase from 21.4% to 32.6%, attributed to a reduction in raw material and direct labor costs [1] - Administrative expenses are expected to decrease significantly from HKD 34,300,000 to HKD 24,200,000 due to reduced employee costs [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 PERFECTECH INTERNATIONAL HOLDINGS LIMITED 威發國際集團有限公司* （於百慕達註冊成立之有限公司） （股份編號：00765） （「本公司」，連同其附屬公司統稱「本集團」） 盈利預告 — 虧損減少 本公告乃本公司根據香港聯合交易所有限公司證券上市規則（「上市規則」）第 13.09(2)(a)條及香港法例第571章證券及期貨條例第XIVA部項下內幕消息條文（定 義見上市規則）而刊發。 本公司董事（「董事」）會（「董事會」）謹此知會本公司股東（「股東」）及潛在投資者，根 據管理層對本集團截至二零二五年六月三十日止六個月之未經審核管理賬目的初步 評估及董事會現時可用的其他資料，本集團預期於截至二零二五年六月三十日止六 個月的綜合淨虧損，將較截至二零二四年六月三十日止六個月的綜合淨虧損 19,400,000港元減少74至79%，主要由於以下各項所致： – 1 – (1) 毛 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 FF301 致：香港交易及結算所有限公司 公司名稱: 威發國際集團有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00765 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 700,000,000 | HKD | | 0.1 | HKD | | 70,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 700,000,000 | HKD | | 0.1 | HKD | | 70,000,000 | 本月底法定/註冊股本 ...